Alise Reicin
Director/Board Member bij SANA BIOTECHNOLOGY, INC.
Vermogen: - $ op 31-03-2024
Profiel
Alise S.
Reicin is currently serving as the President, Chief Executive Officer & Director at Tectonic Therapeutic, Inc. She is also a Director at Sharsheret, Inc., an Independent Director at Sana Biotechnology, Inc., and a Venture Advisor at Israel Biotech Fund.
Previously, she held positions as an Independent Director at Homology Medicines, Inc., President-Global Clinical Development at Celgene Corp., VP-Oncology Program & Pipeline Leadership at Merck & Co., Inc., Head-Global Clinical Development at EMD Serono, Inc., and Member at Columbia University Vagelos College of Physicians & Surgeons.
Dr. Reicin completed her undergraduate degree at Barnard College in 1982 and obtained her doctorate from Harvard Medical School in 1987.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
-.--% | 14-06-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
SANA BIOTECHNOLOGY, INC.
-.--% | 03-04-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Alise Reicin
| Bedrijven | Functie | Begin |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Director/Board Member | 01-12-2020 |
Tectonic Therapeutic, Inc.
 Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Tectonic Therapeutic, Inc. is a biotech company based in Watertown, MA. Tectonic is focused on transforming the discovery of antibodies and other biologic drugs targeting G-protein coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company's proprietary Geode platform aims to unlock the therapeutic utility of the most difficult receptors in the class, which have been considered undruggable with small molecules. The company was founded by Timothy A. Springer and Andrew Kruse of Harvard Medical School. Alise S. Reicin has been the CEO of the company since 2020. | Chief Executive Officer | 01-08-2020 |
Sharsheret, Inc.
 Sharsheret, Inc. Miscellaneous Commercial ServicesCommercial Services Sharsheret, Inc. is a leading Jewish cancer organization that provides free support and educational programs for breast cancer survivors. The non-profit company is based in Teaneck, NJ and the CEO of the company is Elana Silber. The company's program, Best Face Forward 2.0, offers services and subsidies for eligible individuals for non-medical services critical to a woman's quality of life. The company also offers support and resources for those who are BRCA+ or have a family history of BRCA. | Director/Board Member | - |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Consultant / Advisor | - |
Eerdere bekende functies van Alise Reicin
| Bedrijven | Functie | Einde |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01-12-2019 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Chief Tech/Sci/R&D Officer | 01-10-2018 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| Columbia University Vagelos College of Physicians & Surgeons | Corporate Officer/Principal | - |
| Q32 BIO INC. | Director/Board Member | - |
Opleiding van Alise Reicin
| Barnard College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Sharsheret, Inc.
Sharsheret, Inc. Miscellaneous Commercial ServicesCommercial Services Sharsheret, Inc. is a leading Jewish cancer organization that provides free support and educational programs for breast cancer survivors. The non-profit company is based in Teaneck, NJ and the CEO of the company is Elana Silber. The company's program, Best Face Forward 2.0, offers services and subsidies for eligible individuals for non-medical services critical to a woman's quality of life. The company also offers support and resources for those who are BRCA+ or have a family history of BRCA. | Commercial Services |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Tectonic Therapeutic, Inc. is a biotech company based in Watertown, MA. Tectonic is focused on transforming the discovery of antibodies and other biologic drugs targeting G-protein coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company's proprietary Geode platform aims to unlock the therapeutic utility of the most difficult receptors in the class, which have been considered undruggable with small molecules. The company was founded by Timothy A. Springer and Andrew Kruse of Harvard Medical School. Alise S. Reicin has been the CEO of the company since 2020. | Commercial Services |
